ID   CAPON_RAT               Reviewed;         503 AA.
AC   O54960;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-OCT-2024, entry version 133.
DE   RecName: Full=Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein {ECO:0000305};
DE   AltName: Full=C-terminal PDZ ligand of neuronal nitric oxide synthase protein;
DE   AltName: Full=Nitric oxide synthase 1 adaptor protein;
GN   Name=Nos1ap {ECO:0000312|RGD:620106}; Synonyms=Capon;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH
RP   NOS1, AND MUTAGENESIS OF ILE-501; ALA-502 AND VAL-503.
RX   PubMed=9459447; DOI=10.1016/s0896-6273(00)80439-0;
RA   Jaffrey S.R., Snowman A.M., Eliasson M.J.L., Cohen N.A., Snyder S.H.;
RT   "CAPON: a protein associated with neuronal nitric oxide synthase that
RT   regulates its interactions with PSD95.";
RL   Neuron 20:115-124(1998).
RN   [2]
RP   INTERACTION WITH DLG4.
RX   PubMed=10623522; DOI=10.1006/jmbi.1999.3350;
RA   Tochio H., Hung F., Li M., Bredt D.S., Zhang M.;
RT   "Solution structure and backbone dynamics of the second PDZ domain of
RT   postsynaptic density-95.";
RL   J. Mol. Biol. 295:225-237(2000).
RN   [3]
RP   INTERACTION WITH RASD1 AND NOS1.
RX   PubMed=11086993; DOI=10.1016/s0896-6273(00)00095-7;
RA   Fang M., Jaffrey S.R., Sawa A., Ye K., Luo X., Snyder S.H.;
RT   "Dexras1: a G protein specifically coupled to neuronal nitric oxide
RT   synthase via CAPON.";
RL   Neuron 28:183-193(2000).
RN   [4]
RP   INTERACTION WITH NOS1; SYN1; SYN2 AND SYN3.
RX   PubMed=11867766; DOI=10.1073/pnas.261705799;
RA   Jaffrey S.R., Benfenati F., Snowman A.M., Czernik A.J., Snyder S.H.;
RT   "Neuronal nitric-oxide synthase localization mediated by a ternary complex
RT   with synapsin and CAPON.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:3199-3204(2002).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=33523862; DOI=10.1126/sciadv.abe1386;
RA   Majmundar A.J., Buerger F., Forbes T.A., Klaembt V., Schneider R.,
RA   Deutsch K., Kitzler T.M., Howden S.E., Scurr M., Tan K.S., Krzeminski M.,
RA   Widmeier E., Braun D.A., Lai E., Ullah I., Amar A., Kolb A., Eddy K.,
RA   Chen C.H., Salmanullah D., Dai R., Nakayama M., Ottlewski I.,
RA   Kolvenbach C.M., Onuchic-Whitford A.C., Mao Y., Mann N., Nabhan M.M.,
RA   Rosen S., Forman-Kay J.D., Soliman N.A., Heilos A., Kain R., Aufricht C.,
RA   Mane S., Lifton R.P., Shril S., Little M.H., Hildebrandt F.;
RT   "Recessive NOS1AP variants impair actin remodeling and cause glomerulopathy
RT   in humans and mice.";
RL   Sci. Adv. 7:0-0(2021).
CC   -!- FUNCTION: Adapter protein involved in neuronal nitric-oxide (NO)
CC       synthesis regulation via its association with nNOS/NOS1. The complex
CC       formed with NOS1 and synapsins is necessary for specific NO and
CC       synapsin functions at a presynaptic level. Mediates an indirect
CC       interaction between NOS1 and RASD1 leading to enhance the ability of
CC       NOS1 to activate RASD1. Competes with DLG4 for interaction with NOS1,
CC       possibly affecting NOS1 activity by regulating the interaction between
CC       NOS1 and DLG4. In kidney podocytes, plays a role in podosomes and
CC       filopodia formation through CDC42 activation (PubMed:33523862).
CC       {ECO:0000269|PubMed:33523862, ECO:0000269|PubMed:9459447}.
CC   -!- SUBUNIT: Interacts with the PDZ domain of NOS1 or the second PDZ domain
CC       of DLG4 through its C-terminus. Interacts with RASD1 and SYN1, SYN2 and
CC       SYN3 via its PID domain. Forms a ternary complex with NOS1 and RASD1.
CC       Forms a ternary complex with NOS1 and SYN1.
CC       {ECO:0000269|PubMed:10623522, ECO:0000269|PubMed:11086993,
CC       ECO:0000269|PubMed:11867766, ECO:0000269|PubMed:9459447}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, filopodium
CC       {ECO:0000269|PubMed:33523862}. Cell projection, podosome
CC       {ECO:0000269|PubMed:33523862}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain. Highly expressed in
CC       accessory olfactory bulb, caudate-putamen, cerebellum, cerebral cortex,
CC       dentate gyrus of the hippocampus, islands of Calleja, olfactory bulb
CC       and supraoptic nucleus. Expressed in kidney glomeruli podocytes (at
CC       protein level) (PubMed:33523862). {ECO:0000269|PubMed:33523862,
CC       ECO:0000269|PubMed:9459447}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF037071; AAC40065.1; -; mRNA.
DR   RefSeq; NP_620277.1; NM_138922.1.
DR   AlphaFoldDB; O54960; -.
DR   SMR; O54960; -.
DR   CORUM; O54960; -.
DR   IntAct; O54960; 2.
DR   MINT; O54960; -.
DR   STRING; 10116.ENSRNOP00000038197; -.
DR   GlyGen; O54960; 5 sites, 1 O-linked glycan (5 sites).
DR   iPTMnet; O54960; -.
DR   PhosphoSitePlus; O54960; -.
DR   PaxDb; 10116-ENSRNOP00000038197; -.
DR   PeptideAtlas; O54960; -.
DR   GeneID; 192363; -.
DR   KEGG; rno:192363; -.
DR   UCSC; RGD:620106; rat.
DR   AGR; RGD:620106; -.
DR   CTD; 9722; -.
DR   RGD; 620106; Nos1ap.
DR   eggNOG; KOG4458; Eukaryota.
DR   eggNOG; KOG4815; Eukaryota.
DR   InParanoid; O54960; -.
DR   OrthoDB; 2917768at2759; -.
DR   PhylomeDB; O54960; -.
DR   PRO; PR:O54960; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0002102; C:podosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:RGD.
DR   GO; GO:0002020; F:protease binding; IPI:RGD.
DR   GO; GO:0035591; F:signaling adaptor activity; IDA:UniProtKB.
DR   GO; GO:0031102; P:neuron projection regeneration; IEP:RGD.
DR   GO; GO:0007269; P:neurotransmitter secretion; NAS:UniProtKB.
DR   GO; GO:2000170; P:positive regulation of peptidyl-cysteine S-nitrosylation; IMP:BHF-UCL.
DR   GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:1902514; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; IDA:BHF-UCL.
DR   GO; GO:0098901; P:regulation of cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0003062; P:regulation of heart rate by chemical signal; ISO:RGD.
DR   GO; GO:1901841; P:regulation of high voltage-gated calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0045428; P:regulation of nitric oxide biosynthetic process; TAS:DFLAT.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:DFLAT.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; ISO:RGD.
DR   CDD; cd01270; PTB_CAPON-like; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR051133; Adapter_Engulfment-Domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   PANTHER; PTHR11232:SF76; CARBOXYL-TERMINAL PDZ LIGAND OF NEURONAL NITRIC OXIDE SYNTHASE PROTEIN; 1.
DR   PANTHER; PTHR11232; PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING FAMILY MEMBER; 1.
DR   Pfam; PF00640; PID; 1.
DR   SMART; SM00462; PTB; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS01179; PID; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell projection; Coiled coil; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..503
FT                   /note="Carboxyl-terminal PDZ ligand of neuronal nitric
FT                   oxide synthase protein"
FT                   /id="PRO_0000089318"
FT   DOMAIN          26..191
FT                   /note="PID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00148"
FT   REGION          170..212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..285
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          491..503
FT                   /note="Interaction with NOS1"
FT   COILED          319..360
FT                   /evidence="ECO:0000255"
FT   MOTIF           501..503
FT                   /note="PDZ-binding"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75052"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3A8"
FT   MUTAGEN         501
FT                   /note="I->S,A: Does not affect interaction with NOS1."
FT                   /evidence="ECO:0000269|PubMed:9459447"
FT   MUTAGEN         502
FT                   /note="A->D: Abolishes interaction with NOS1."
FT                   /evidence="ECO:0000269|PubMed:9459447"
FT   MUTAGEN         503
FT                   /note="V->A: Abolishes interaction with NOS1."
FT                   /evidence="ECO:0000269|PubMed:9459447"
SQ   SEQUENCE   503 AA;  55864 MW;  801775EB2BF49EFC CRC64;
     MPSKTKYNLV DDGHDLRIPL HNEDAFQHGI SFEAKYVGSL DVPRPNSRVE IVAAMRRIRY
     EFKAKNIKKK KVSIMVSVDG VKVILKKKKK KKEWTWDESK MLVMQDPIYR IFYVSHDSQD
     LKIFSYIARD GASNIFRCNV FKSKKKSQAM RIVRTVGQAF EVCHKLSLQH TQQNADGQED
     GESERNSDGS GDPGRQLTGA ERVSTATAEE TDIDAVEVPL PGNDILEFSR GVTDLDAIGK
     DGGSHIDTTV SPHPQEPMLA ASPRMLLPSS SSSKPPGLGT GTPLSTHHQM QLLQQLLQQQ
     QQQTQVAVAQ VHLLKDQLAA EAAARLEAQA RVHQLLLQNK DMLQHISLLV KQVQELELKL
     SGQSTMGSQD SLLEITFRSG ALPVLCESTT PKPEDLHSPL LGAGLADFAH PVGSPLGRRD
     CLVKLECFRF LPAEDNQPMA QGEPLLGGLE LIKFRESGIA SEYESNTDES EERDSWSQEE
     LPRLLNVLQR QELGDSLDDE IAV
//
